KIT and intrahepatic cholangiocarcinoma: The MEK-MAPK pathway and the subsequent expression of ETV1, a master regulator of an ICC-GIST-specific transcription network and KIT expression [23], is predominantly activated in NF1-GISTs [15], which may result in strong KIT-positivity in immunohistochemistry.